Skip to main content

24-09-2016 | Skin cancers | Article

Primary and Secondary Chemoprevention of Malignant Melanoma

American Journal of Clinical Dermatology

Authors: Jessica Mounessa, Talayesa Buntinx-Krieg, Rosie Qin, Cory A. Dunnick, Robert P. Dellavalle

Publisher: Springer International Publishing


The incidence of malignant melanoma (MM) continues to rise in the United States. While sun protection and full body skin examinations remain the mainstay of preventative care, chemoprevention of the deadly disease has become an increasingly popular field of study. In this focused review, we discuss current findings and analyze the risks and benefits of various agents investigated for the primary and secondary chemoprevention of MM. Such agents include topical retinoids, vitamins, and supplements, Polypodium leucotomas extracts, non-steroidal anti-inflammatory agents (NSAIDs), statins, sunscreens, and field therapy with topical imiquimod for primary and secondary chemoprevention. We further identify a need for expanded high quality human research on the topic.

Please log in to get access to this content

Related topics